The Association Between Type of Fat and the Risk of Developing Cardiovascular Diseases by Glassner, Dovid Leib
The Science Journal of the Lander College of Arts and Sciences 
Volume 12 
Number 1 Fall 2018 Article 7 
2018 
The Association Between Type of Fat and the Risk of Developing 
Cardiovascular Diseases 
Dovid Leib Glassner 
Touro College 
Follow this and additional works at: https://touroscholar.touro.edu/sjlcas 
 Part of the Biology Commons, Cardiovascular Diseases Commons, and the Pharmacology, Toxicology 
and Environmental Health Commons 
Recommended Citation 
Glassner, D. L. (2018). The Association Between Type of Fat and the Risk of Developing Cardiovascular 
Diseases. The Science Journal of the Lander College of Arts and Sciences, 12 (1). Retrieved from 
This Article is brought to you for free and open access by the Lander College of Arts and Sciences at Touro Scholar. 
It has been accepted for inclusion in The Science Journal of the Lander College of Arts and Sciences by an 
authorized editor of Touro Scholar. For more information, please contact Timothy J Valente 
timothy.valente@touro.edu. 
39
Abstract
Objective: To determine the significance of various types of dietary fat in the progression of atherosclerosis leading to heart disease.
Methods: Study inclusion criteria constituted relevance to the discussion topic and peer reviewed literature. Age of the published 
material was taken into account as well, with greater preference being given to more recent research as the topic of nutrition and 
its relation to chronic disease remains an emerging science. 
Results: This research review found an overall significant relationship between the type (monounsaturated, polyunsaturated, sat-
urated and trans-fat) of dietary fat intake and the incidence of cardiovascular disease. While earlier research identified an 
increased risk of cardiovascular disease to be associated with an overall increased intake of dietary fat, newer studies recognized 
the increased risk to be associated more specifically with saturated and trans fatty acids. Substitution of other dietary fats in 
place of saturated fat in the diet also plays a role in cardiovascular disease. The studies reviewed here found a protective effect 
of polyunsaturated fatty acids when replacing saturated fat in the diet. On the other hand, replacing saturated fats with carbo-
hydrates has no evidence of improved cardiovascular health. Studies looking at the implications of substituting saturated fat with 
monounsaturated fats remain inconclusive at this time.  Aside from dietary fat intake, the progression of atherosclerosis leading to 
cardiovascular disease can be caused by oxidative stress such as in the case of hyperglycemia and diabetes. 
Conclusions: As health care costs continue to rise in this country, preventive medicine plays an increasingly important role in the 
prevention and treatment of chronic disease. Research shows that decreasing the percentage of saturated fats in the diet and sub-
stituting these with healthier polyunsaturated fats, as well as minimizing oxidative stress in the body can decrease the incidence 
of cardiovascular disease, a leading cause of death in the United States. 
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Dovid Leib Glassner
Dovid Leib Glassner graduated June 2018 with a Bachelor’s of Science in Biology and is currently pursuing medical school.
Introduction
In February of 1980 the United States Department of Agriculture 
and Department of Health and Human Services jointly pub-
lished the first set of Dietary Guidelines for Americans. During 
this time, health scientists were beginning to focus on the link 
between macronutrient intake and a correlated risk for chronic 
diseases. In these original guidelines, Americans were encour-
aged to keep their total fat intake levels below thirty percent of 
their diet, have less than ten percent of dietary fat come from 
saturated fat, and maintain a cholesterol intake that was under 
300 mg per day (Canty, 2018).
The guidelines have been updated every five years since and 
have evolved based on accumulating scientific evidence, popu-
lation patterns in health status, food consumption, and physical 
activity. The 2015 Dietary Guidelines have a stronger emphasis 
on healthy eating patterns and regular physical activity. However, 
there has been minimal change in the recommendations for fat 
intake for almost 40 years since the first set of guidelines. In 
2015, the Dietary Guidelines for Americans recommended that 
fat be 20-35% of the diet with less than 10% coming from sat-
urated fat and minimizing trans fats as much as possible. While 
the 2015 guidelines did not address cholesterol, the recommen-
dations from 2010 remain the same as well (<300 mg/day) (U.S. 
Dept. of Health and Human Services, 2015). 
Controlling fat intake has consistently been recommended to 
improve health for Americans with a specific focus on limiting 
saturated fat in the diet. However, heart disease, a form of car-
diovascular disease, remains to be the leading cause of death 
for both men and women worldwide. Stroke, a complication of 
cardiovascular disease is the fifth leading cause of death in the 
Unites States. Dietary fat intake is a major modifiable risk factor 
in the development and progression of cardiovascular disease. 
(Center for Disease Control, 2017).
Methods
Studies reviewed in this paper were selected from journal data-
bases, library catalogs, and Health and Nutrition Science profes-
sional websites. Papers were gathered from PubMed, CINAHL, 
Medline, and similar scientific search engines using advanced 
search phrases “PUFA,” “MUFA,” “dietary fat intake,” “trans-fat,” 
“oxidative stress” and “CVD”.
The writer considered over 36 papers and over 20 papers 
were included in the final research review. Study inclusion crite-
ria consisted of relevance to the discussion topic and peer-re-
viewed literature.  Age of the published material was taken into 
account as well, with greater preference being given to more 
recent research as the topic of nutrition and its relation to 
chronic disease remains an emerging science.
To improve the writer and reader’s understanding of the rela-
tion between dietary fat intake and disease, noted textbooks in 
advanced biochemistry topics were referenced and included in 
the discussion section of this paper. 
Discussion
Fat is an essential macronutrient required by the body. In 1927, 
the effects of fat deficiency on growth and development in-
spired researchers Evans and Burrs to dub fat “vitamin F”. Two 
years later, in 1929, Evans and Burrs found that a fat-free diet in 
weanling rats produced impaired growth, scaly skin, tail necro-
sis, increased mortality, and impaired fertility (Ross, et. al, 2014). 
These symptoms were reversed when provided with linoleic or 
linolenic acid and the term “essential fatty acids” was coined. 
Almost thirty years later, in 1958, Essential Fatty Acid Deficiency 
(EFAD) was first demonstrated in humans, when infants fed a 
milk-based diet lacking essential fatty acids (EFA) showed severe 
skin symptoms alleviated by the addition of linoleic acid. Total 
Parenteral Nutrition Support, lacking fat-soluble vitamins, was 
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also shown to produce EFAD in a 6-year-old girl maintained on 
total parenteral nutrition for five months (Burr, 1981).
We require fat and fat-soluble vitamins for energy reserves, 
cell signaling, synthesis of hormones, and their structural role in 
cell membranes (Canty, 2018). The average intake of fat in this 
country has remained relatively consistent since the 1990s. 
The average American consumes 33% of his calories from fat 
and 10% from saturated fat. There were significant changes over 
the years in the consumption of monounsaturated fat (MUFA) 
(14.6% to 13%, p = 0.03) and polyunsaturated fat (PUFA) (6.9%-
8.0%, p = <0.001) as well as the ratio of PUFAs to saturated fat 
(7.1%-8.1%, p = < 0.001) (fig. 1) (Vadiveloo, at. al. 2013).
Atherosclerosis is the narrowing of the arterial wall caused 
by a buildup of plaque. As the endothelial layer on the artery 
wall weakens, it becomes susceptible to plaque accumulation by 
a high concentration of Low-Density Lipoprotein (LDL) -cho-
lesterol in the blood. As the plaque begins to build, monocytes 
and macrophages are attracted to the site of the plaque con-
tributing to stenosis (Narrowing of the artery lumen). The layer 
of smooth muscle in the artery begins to grow a fibrous cap 
over the plaque. As the plaque continues to develop, this cap can 
rupture and form a blood clot that may cause a heart attack or a 
stroke (Escott-Stump, 2015, Mahan and Raymond, 2017). 
Types of Fats
As part of the Strong Heart Study, researchers examined the 
association between dietary fat intake and coronary heart dis-
ease in 2,938 Indian American adults ages 45-79 for an average 
of 7 years. Over 400 participants experienced Coronary Heart 
Disease (CHD) during this time, including 138 fatalities. The re-
searchers divided participants into two age group categories, 
47-59 years and 60-79 years. Across both age groups, individuals 
who developed CHD were more likely male, hypertensive and 
with lower High-Density LipoProteins (HDL) levels and higher 
serum triglycerides. Amongst the older group, those that devel-
oped CHD had higher LDL levels as well. Amongst the younger 
group, an increasing rate of mortality due to CHD was seen 
with greater quartiles of total fat intake, specifically saturated 
and monounsaturated fat (Lee, et. Al. 1990). This study suggests 
that abnormal lipoprotein levels (low HDL, high LDL) are asso-
ciated with an increased morbidity in adults. Additionally, total 
fat, rather than a specific type of fat, is associated with increased 
mortality from CHD.
The Seven Countries Study (Keys, et. al. 1984) investigated the 
intake of various fatty acids as well as dietary cholesterol in rela-
tion to serum cholesterol and 25-year mortality from coronary 
heart disease. The study was carried out from 1956-1964 and 
constituted 16 cohorts across seven countries to include over 
12,000 men between the ages of 40-59 years. Dietary intake data 
was collected and standardized by one dietitian. In 1960 total 
lipids were measured (at that time there was no instrument avail-
able to measure trans-fat, omega-3 or omega-6 fatty acids). Data 
was collected and reported for saturated, monounsaturated and 
polyunsaturated fats. Later, in 1987, total lipids were isolated and 
cis and trans fats, as well as omega-3 fatty acids, were identified. 
The individual saturated fatty acids, namely lauric acid and myris-
tic acid, were significantly related to cholesterol levels (p < 0.001). 
Moreover, the researchers identified a strong positive relation-
ship between the intake of saturated fats and death rates from 
CHD (p <0.001) (fig. 2). It is worthwhile to note that a 25-year 
lapse in time from the collection of data to the analysis may have 
impacted the researchers’ findings.
More recent studies support these findings as well, indicating 
that the source of dietary fat influences heart disease. A 20 year 
follow up of the Nurses’ Health Study looked at the associ-
ation specific types of dietary fat intake as they relate to the 
risk of coronary heart disease. The study consisted of 78,778 
US women who were without CVD or diabetes at the initi-
ation of the study in 1980. At the follow up, 1,766 incidences 
of CHD were reported, 525 of which were fatal. Researchers 
found that intake of polyunsaturated fats was inversely associ-
ated with CHD (P = 0.004) (fig. 3). The results were substantial 
amongst women with an overweight BMI (>35 kg/m2). Trans-fat 
intake was associated with an increased risk of developing CHD 
(P=0.01), particularly in women under 65 years of age (Colditz, 
Hankinson, 2005).
Figure 1: Trends in dietary fat consumption (NHANES)
Source: Canty, D. Advanced Nutrition: Protein, Fats and Carbohydrates. 
Spring 2018.
Figure 2: Correlations Between Fat Intakes (E%) and Serum 
Cholesterol and 25y CHD Death Rate 
Source: Canty, D. Advanced Nutrition: Protein, Fats and 
Carbohydrates. Spring 2018.
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These findings are consistent with a 2006 cross-sectional 
study of 1,123 adults between the ages of 20 and 98 explaining 
the possible connection between the inverse relationships. The 
researchers looked at the relationship between fasting plasma 
polyunsaturated fatty acid (PUFA) levels and markers of inflam-
mation. They found a statistically significant, negative correlation 
between the intake of PUFAs, specifically omega-3 and omega-6 
fatty acids and plasma levels of pro-inflammatory markers (IL-6, 
TNF, IL-10, CRP). This study suggests that the anti-inflammatory 
properties of polyunsaturated fatty acids are associated with 
lowering plasma levels of pro-inflammatory markers that play a 
role in the progression of atherosclerosis (Ferruci, et. Al. 2006)
Replacing Saturated Fat in the Diet
Current guidelines from the HHS and USDA recommend <10% 
of calories come from saturated fat and the American Heart 
Association recommends no more than 5-6% of intake should 
come from saturated fat to decrease LDL cholesterol. However, 
there are fewer studies and recommendations discussing what the 
recommended replacement for saturated fat in the diet should be. 
A meta-analysis of eight randomized control trials that includ-
ed over 1,000 incidences of CHD amongst 13,614 participants, 
found that increased PUFA intake in place of saturated fat in 
the diet reduced CHD events by 19% (Mozaffarian, et. Al. 2010). 
More specifically, each 5% increase in PUFA consumption re-
duced the risk of CHD by 10%. The analysis suggests that these 
improvements in the incidence of CHD were likely the effect 
that PUFAs had on lowering LDL in the blood. The short-term 
studies part of this identified a 5% energy intake from PUFAs 
that replaced a 5% energy intake from saturated fat lowered 
LDL cholesterol by 10 mg/dl while having no significant impact 
on HDL cholesterol. This intake of PUFAs in place of saturat-
ed fats lowered the total cholesterol to HDL ratio by 0.16. 
Conversely, no change in the total cholesterol to HDL ratio 
was found when saturated fat in the diet was replaced with 
carbohydrates. The observational studies identified a 44% de-
crease in CHD risk associated with each unit decrease of total 
cholesterol to HDL ratio.
It is important to note that these studies measured the effects 
of replacing saturated fatty acids with PUFAs in the diet and 
therefore cannot ascertain whether the benefits were relat-
ed to the decrease in saturated fatty acids or the increase in 
dietary PUFAs.  It can be concluded that replacing saturated 
fats with PUFAs in the diet likely decreases the incidence of 
CHD while replacing saturated fat with carbohydrates does not. 
Consequently, it may be concluded that the effects of replacing 
saturated fat in the diet with monounsaturated fat are mixed. 
Future studies looking at the implication of replacing saturated 
fat with proteins and/or MUFAs would be beneficial.
Animal vs. Plant Fats
Emerging research looked at monounsaturated fatty acids to 
identify if the source of MUFAs had a relationship to its im-
pact on heart disease. Researchers used data from the Nurses’ 
Health Study that included 63,000 women and data from the 
Health Professionals Follow-Up study that included 30,000 men. 
Both of these studies utilized food frequency questionnaires ad-
ministered every four years to evaluate participants’ diets.
When analyzed, participants with a higher intake of MUFAs 
from plant sources showed a 16% lower risk of death (from any 
cause) compared with those that had a lower intake. In contrast, 
participants with a higher intake of MUFAs coming from animal 
protein exhibited a 21% increase in risk of death related to any 
cause. Replacing dietary MUFAs from animal sources for the 
equivalent per gram in plant sources may lower the risk for 
death by heart disease or any cause of death between 24% and 
26% (Roeder, 2018).
Similar findings have been reported for with saturated fat. It is 
thought that plant sources of saturated fat may,  in fact, play less 
of a role in the morbidity and mortality from coronary heart 
disease than animal sources. These findings can be explained 
by a recent study looking at the structural implications of fatty 
acids. An animal source of saturated fatty acids is located mainly 
at the sn-2 position of the glycerol backbone as shown in figure 
5 and affects the metabolism, functionality, and physiological ef-
fects of the saturated fatty acids (fig. 4) (Nettelton, et. al. 2017).
The Multi-Ethnic Study of Atherosclerosis aimed to determine 
the association between SFA intake from varying food service 
and in the incidence of CVD. The study included 5,209 par-
ticipants between the ages of 45–84 that were followed for a 
Figure 3: Fat intake and CHD risk in women; Nurse’s Health Study 
20y Follow-up 
Source: Canty, D. Advanced Nutrition: Protein, Fats and Carbohydrates. 
Spring 2018.
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Figure 4: Implications of Structure and Position of Saturated 
Fatty Acids Source: Nettleton, 2017.
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decade from 2000. Diet was assessed using a food frequency 
questionnaire and over 300 cases of CVD were assessed during 
follow up valuations.
After adjusting for confounding factors, researchers conclud-
ed that a higher intake of saturated fat from dairy sources was 
associated with a lower risk of CVD (95% CI for + 5 grams per 
day and 5% of energy intake from dairy sources of saturated fat). 
In contrast, meat saturated fat was associated with an increased 
risk of developing CVD with the same increase in grams per day 
and % energy intake (fig. 5). 
Substituting 2% of energy intake from meat sources of satu-
rated fat with dairy sources of saturated fat was associated with 
a 25% decreased risk of CVD (Otto, et. al. 2012). This particular 
study found no association between CVD and intake of plant 
or butter saturated fats, however, intakes recorded in the Food 
Frequency Questionnaires were narrow. 
Processed Fat: Trans Fat
Since in 2006, food manufacturers have been required to list 
trans-fat on all food labels. Trans fats (trans unsaturated fatty 
acids) are artificially produced solid fats. Liquid vegetable oils are 
heated with catalysts in a process called hydrogenation, which 
breaks double bonds in unsaturated fats and adds hydrogens, 
thereby solidifying the fat, making it a solid at room temperature. 
The current dietary guidelines for healthy Americans recom-
mend keeping trans-fat intake “as low as possible” (< 10% of 
total calories). These recommendations are based on studies 
that have found that trans fats increase LDL-cholesterol levels 
in the blood while decreasing healthy levels of HDL-cholesterol. 
One early study demonstrated this by providing 34 adult women 
and 25 adult men with three diets that each study subject fol-
lowed for three consecutive weeks. All three diets were mixed, 
natural diets and identical in nutrient consumption except for 
10% of energy intake coming from oleic acid (a monounsat-
urated fat with one cis bond), trans isomers of oleic acid, or 
saturated fatty acids. LDL cholesterol was significantly higher 
on the trans fatty acid diet compared to the other two diets (P 
<0.0001) with no significant differences found between men and 
women (Mensink, Katan, 1990).
A significant relationship has been reported between dietary 
trans-fat and coronary heart disease. Dietary data was stud-
ied from participants in the Nurses’ Health Study and intake of 
trans fat was calculated using the questionnaires completed by 
more than 80,000 female participants, all of whom were with-
out diagnosed cardiovascular disease at the time. Over the 8 
year follow up period, 431 cases of new CHD were diagnosed. 
Adjusting for age and total caloric intake, the intake of trans 
fat was directly related to increased risk of CHD (P = 0.001). 
Margarines, cookies, cakes and refined white bread were each 
significantly associated with an increased risk of developing 
CHD, with a stronger association found for the participants 
who stated consistent margarine intake for the last 10 years 
(Willett, 1993). 
More recently, the DASH diet (Dietary Approach to Stop 
Hypertension) has been found to reduce the risk of cardiovas-
cular disease in women. The DASH diet focuses on consuming 
adequate servings of fruits and vegetables, lean proteins and 
limiting intake of saturated and trans fatty acids (2 a day where 
a serving is 1 teaspoon of margarine). A study followed more 
than 88,000 women between the ages of 34 and 59 years. Food 
frequency questionnaires were collected 7 times between 1980 
and 2004. Over 2,000 cases of nonfatal myocardial infarction, 
over 3,000 strokes and 976 women died of CHD over the 24-
year follow-up period. After adjusting for confounding factors, 
increased DASH scores were associated with decreased risk of 
acquiring some form of CVD (P <0.01) (Fung, et. al. 2018).
Do PUFAs Have any Faults in Relation to Disease?
Lipid peroxidation is the oxidative deterioration of lipids pos-
sessing double bonds by interaction with a reactive oxygen spe-
cies (ROS). Given their higher content of double bonds, PUFAs 
are more susceptible to oxidation than SFAs and even MUFAs. 
Antioxidants, such as vitamin E and vitamin C, in our diets and 
in our bodies, serve to detoxify the oxidative damage caused by 
ROS. In a healthy individual, the generation of reactive oxygen 
species is in normal balance with antioxidant activity. However, 
increasing amounts of oxidative damage and/or decreasing 
amounts of antioxidants leads to oxidative stress in which ele-
vated levels of ROSs can lead to oxidative damaging of proteins, 
carbohydrates and DNA molecules. 
Oxidative stress has been linked to disease states such as ath-
erosclerosis and certain cancers. The question remains whether 
the disease state causes the increased lipid peroxidation and 
oxidative stress or if the oxidative damage leads to the disease 
state (Ross, et. al, 2014).
Coconut Oil: Celebrity Status Threatened
The American Heart Association published a 2018 Presidential 
Figure 5: Dietary Source of Saturated Fat May Affect CVD Risk
Source: Canty, D. Advanced Nutrition: Protein, Fats and 
Carbohydrates. Spring 2018.
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Advisory that had much of the health community involved in a 
conversation regarding saturated fats and their role in oxidative 
damage and chronic disease. The AHA’s advisory mentioned a 
New York Times piece highlighting a recent health survey in the 
United States which found that 73% of Americans classified coco-
nut oil as a “health food” compared to 37% of nutritionists. The 
AHA contributes the positive perception of coconut oil in its 
relation to health promotion and disease prevention to a result 
of good marketing by the coconut oil industry (Sacks, et. al. 2017).
Statistics from the USDA reveal that coconut oil consumption 
increased from 2013 to 2014 by 9.55% and then dropped in 
2014 and 2015 to 6.23% and 13.47% respectively. This informa-
tion sheds some light on the increased promotion of coconut 
oil as a health food by the coconut oil industry and the belief 
of Americans, that it is a health food.  However, coconut oil’s 
nutrition profile did not change during this time. It remains to 
be 82% saturated fat, and like all densely saturated fats, plays a 
role in cardiovascular disease.
A recent review looked at seven interventional studies com-
paring coconut oil with unsaturated fats in the diet and their 
individual influences on lipid profiles of study participants. All 
seven trials resulted in higher total cholesterol for those receiv-
ing coconut oil intervention, all of which were statistically signif-
icant. Six out of the seven studies found a statistically significant 
increase of LDL cholesterol for the intervention group.  HDL 
levels were statistically significantly raised in five studies for 
those receiving the coconut oil intervention (Eyres, et. al. 2016). 
The AHA warns consumers that the HDL improvements seen 
with diet or drug treatment cannot be directly linked to changes 
in CVD occurrences and therefore encourages Americans to 
look at the LDL changes as effected by various fats alone in 
regard to their role in CVD (Sacks, et. al. 2017). 
Atherosclerosis: Other Players
As the walls of the arteries get thicker, narrowing the lumen 
due to plaque buildup, patients with atherosclerosis experience 
worsening symptoms of CVD, including hypertension (Nelms 
et. al 2016) . During the initial stages of plaque buildup, the en-
dothelial cells of the luminal lining, which provide the barrier 
between the lumen and the vascular wall, may experience dys-
function and contribute to increased plaque and blood pressure. 
Certain stimuli can trigger the dysfunction of the endothelial 
cells, deeming these stimuli proatherogenic. Diabetes and oxida-
tive stress are amongst the major players that contribute to the 
eventual loss of functionality of the endothelial cells, along with 
dyslipidemia, abnormally elevated cholesterol or fats (lipids) in 
the blood (Chistiakov, et. al. 2015).
Glucosamine, often used in the management of osteoarthritis, 
has anti-inflammatory effects by contributing to a redox state in 
an oxidative environment. In an attempt to take advantage of its 
properties, glucosamine supplements consisting of 300 mg were 
given to 20 individuals daily for 30 days and arteriosclerosis and 
CVD were compared to 19 controls. Flow-mediated vasodila-
tion was monitored in all participants at the start and for the 
duration of the four-week trial.  At the end of four weeks, pa-
rameters such as blood pressure, blood glucose, and lipid levels 
were measured. No significant changes were found in these clin-
ical markers prior to or following the study between the two 
groups. However, glucosamine supplementation significantly 
improved flow-mediated vasodilation (P = 0.02) highlighting the 
role that oxidative stress independently plays in atherosclerosis 
and cardiovascular disease (Katoh, et. al. 2017).
This is similar to what is seen in the strong correlation be-
tween diabetes, specifically type 2, and incidence of CVD. The 
American Heart Association considers diabetes to be one of 
the seven top causes of cardiovascular disease. More than 68% 
of people over the age of 65 with diabetes will die from a form 
of heart disease. Adults with diabetes are twice to four times as 
likely to die of heart disease than adults of the same age without 
diabetes (American Heart Association, 2018). 
Oxidative stress has been shown to contribute to athero-
sclerotic buildup in animal models. Elevated blood glucose in 
type 2 diabetic patients allows for glucose persisting in the 
bloodstream to become damaged, increases the amount and 
rate at which reactive oxygen species (ROS) accumulate. ROS 
are potent oxidants that, without adequate antioxidant activity, 
can proliferate and cause oxidative damage in individuals leading 
to the dysfunction and apoptosis of endothelial cells, worsening 
atherosclerosis and hypertension leading to worsening cardio-
vascular complications (Jay, et. al. 2006). 
A double-blinded crossover study looked at the role that 
antioxidants could play in lowering levels of ROS and oxidative 
stress and mortality risk due to CVD in diabetes over the age 
of 55.  Exclusion criteria included uncontrolled hypertension 
and history of a myocardial infarction and/or stroke within the 
last month. Participants were randomized to receive either 
a vitamin E (a potent Anti-oxidant) supplement or a placebo 
pill. At the end of eight weeks, researchers measured forearm 
blood flow and found that vitamin E supplementation signifi-
cantly improved blood flow (P <0.01), demonstrating improved 
cardiovascular profiles in diabetic patients receiving antioxidant 
supplementation (Alshiek, et. al. 2017).
Implications
The Lifestyle Heart Trial suggests a correlation between a life-
style change in patients with atherosclerosis and regression in 
their artery lesions. Forty-one participants with atherosclerosis 
were randomized to an experimental group (n=22) and control 
group (n=19). Angiographies were conducted at baseline and 
again at a one-year follow-up. During the year the experimental 
group was given a low-fat, vegetarian diet with less than 10% 
of calories coming from fat and a ratio of PUFAs to saturated 
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fat  of less than 1. The experimental group was also required 
to participate in aerobic exercise and attend weekly support 
group meetings. Following one year, blood serum was collected 
and analyzed from all 22 participants. The results showed an 
average percentage diameter stenosis decrease from 16.9% to 
16.5% amongst the experimental group. The control group who 
continued with their usual diet and lifestyle showed stenosis 
progression from 15.5% to 18.5%. The average percentage re-
gression in the diameter stenosis of the control group was 82% 
(18 out of 22). In the experimental group, total cholesterol was 
lowered by 24.3% and LDL concentration by 37.4%. This study 
shows that a lifestyle change in patients with coronary heart 
disease can lead to significant regression in arterial stenosis 
(Ornish, et. al. 1990). Changes in lipid profiles and angina pecto-
ris are displayed in the tables (ref., tables 1 and 2).
Conclusions and Recommendations
The Dietary Guidelines for Americans published every five years 
is a set of evidence-based guidelines to promote healthy nutri-
tion habits and prevent nutrition-related disease in the American 
population.  These guidelines are constantly evolving based on the 
latest research findings and available science. Despite its regular 
updates, the DGA has remained relatively consistent in its rec-
ommendation for the dietary consumption of fats. 
Recent National Health and Nutrition Examination Survey 
data shows Americans are consuming 33% of their calories in the 
form of fat. This paper reviewed the literature on types of fats and 
their individual relationship to the progression of cardiovascular 
disease, the cause for one-third of all deaths in this country. 
Indeed, the type of fat a person is consuming impacts his or 
her risk of cardiovascular disease. Higher amounts of saturated 
fat in the diet have been found to be associated with increased 
Mean (SD) at Baseline Mean (SD) at 12 Months
Experimental Group 
(n=20-22)
Control Group 
(n=17-19)
Experimental Group 
(n=20-22)
Control Group 
(n=17-19)
Serum Lipids (mmol/l)
- Total chol
- LDL
- HDL
- Triglycerides
5.88 (1.29)
3.92 (1.25)
1.00 (0.26)
2.38 (1.26)
6.34 (1.02)
4.32 (0.77)
1.35 (0.52)
2.45 (2.47)
4.45 (1.15)
2.46 (1.55)
0.97 (0.40)
2.91 (1.47)
6.00 (1.55)
4.07 (1.17)
1.31 (0.38)
2.24 (1.79)
Lipid Ratios
- Total/HDL
- LDL/HDL
6.33 (2.14)
4.18 (1.53)
5.32 (1.89)
3.59 (1.37)
5.15 (2.23)
2.89 (1.92)
4.93 (1.59)
3.33 (1.42)
Blood Pressure (mm Hg)
- Systolic
- Diastolic
134 (13)
83 (8)
140 (26)
82 (13)
127 (13)
79 (7)
131 (20)
77 (11)
Weight (kg) 91.1 (15.5) 80.4 (22.8) 81.0 (11.4) 81.8 (25.0)
Table 1: Changes in Risk Factors Source: Ornish, D. 1990
Chest pain Mean (SD) at baseline Mean (SD) at 12 months
Experimental Group 
(n=20)
Control Group
(n=17)
Experimental Group 
(n=20)
Control Group 
(n=17)
Frequency 5-10 (14-1) 2-35 (3-77) 0.45 (0.76) 6-24 (12-9)
Duration (min) 2-73 (4-69) 3-47 (7-95) 1-58 (4-48) 6-97 (14-5)
Severity 2-3 (1-6) 1-8 (1-1) 1-7 (1-2) 2-5 (1-2)
Table 2: Changes in Angina Pectoris Source: Ornish, D. 1990
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risk of CVD. Replacing saturated fat with carbohydrates has 
not been found to improve lipid profiles or CVD risk factor 
biomarkers. On the other hand, replacing saturated fat with 
unsaturated fats, specifically PUFAs, have been associated with 
lowering an individual’s risk of developing CVD. The data on 
MUFAs remains inconclusive at this time. 
The research suggests that health care professionals should 
encourage their patients and clients, especially those at risk for 
cardiovascular disease, to consume a diet lower in saturated 
fat and to mindfully replace those items with wholesome, real 
foods, and fats higher in PUFA content while remaining wary 
of processed carbohydrates. As part of a healthy diet, consum-
ers should also consume adequate foods high in antioxidants 
to provide a buffer for the potentially oxidizing effect of a diet 
higher in PUFAs. 
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